The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injection Human Interleukin-2 Market Research Report 2025
Synopsis
Interleukin-2 is ia type of medication called a biologic response modifier. It is a type of protein called a cytokine that works to increase the production and function of some parts of your body's immune system.
The global Injection Human Interleukin-2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Injection Human Interleukin-2 is a crucial biopharmaceutical product used in the fields of immunotherapy and cancer treatment. The market size has been expanding steadily, driven by the ongoing advancements in immunotherapy and the increasing number of cancer patients. Its sales continue to grow globally, making it a key product in the pharmaceutical industry. Specific uses include the treatment of various cancer types such as malignant melanoma, renal cell carcinoma, and leukemia, as well as for patients with immunodeficiency disorders. In the future, as research and clinical applications of immunotherapy further expand, Injection Human Interleukin-2 is poised for significant market development, offering more effective options for the treatment of cancer and immunology-related diseases.
This report aims to provide a comprehensive presentation of the global market for Injection Human Interleukin-2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Human Interleukin-2.
Report Scope
The Injection Human Interleukin-2 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injection Human Interleukin-2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injection Human Interleukin-2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Clinigen
3SBio
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute Of Biological Products
Shandong Quangang Pharmaceutical
Segment by Type
50000 IU
100000 IU
200000 IU
500000 IU
1 Million IU
Other
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injection Human Interleukin-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injection Human Interleukin-2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Interleukin-2 is ia type of medication called a biologic response modifier. It is a type of protein called a cytokine that works to increase the production and function of some parts of your body's immune system.
The global Injection Human Interleukin-2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Injection Human Interleukin-2 is a crucial biopharmaceutical product used in the fields of immunotherapy and cancer treatment. The market size has been expanding steadily, driven by the ongoing advancements in immunotherapy and the increasing number of cancer patients. Its sales continue to grow globally, making it a key product in the pharmaceutical industry. Specific uses include the treatment of various cancer types such as malignant melanoma, renal cell carcinoma, and leukemia, as well as for patients with immunodeficiency disorders. In the future, as research and clinical applications of immunotherapy further expand, Injection Human Interleukin-2 is poised for significant market development, offering more effective options for the treatment of cancer and immunology-related diseases.
This report aims to provide a comprehensive presentation of the global market for Injection Human Interleukin-2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Human Interleukin-2.
Report Scope
The Injection Human Interleukin-2 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injection Human Interleukin-2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injection Human Interleukin-2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Clinigen
3SBio
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute Of Biological Products
Shandong Quangang Pharmaceutical
Segment by Type
50000 IU
100000 IU
200000 IU
500000 IU
1 Million IU
Other
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injection Human Interleukin-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injection Human Interleukin-2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Injection Human Interleukin-2 Market Overview
1.1 Product Overview and Scope of Injection Human Interleukin-2
1.2 Injection Human Interleukin-2 Segment by Type
1.2.1 Global Injection Human Interleukin-2 Market Value Comparison by Type (2024-2030)
1.2.2 50000 IU
1.2.3 100000 IU
1.2.4 200000 IU
1.2.5 500000 IU
1.2.6 1 Million IU
1.2.7 Other
1.3 Injection Human Interleukin-2 Segment by Application
1.3.1 Global Injection Human Interleukin-2 Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Injection Human Interleukin-2 Market Size Estimates and Forecasts
1.4.1 Global Injection Human Interleukin-2 Revenue 2019-2030
1.4.2 Global Injection Human Interleukin-2 Sales 2019-2030
1.4.3 Global Injection Human Interleukin-2 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injection Human Interleukin-2 Market Competition by Manufacturers
2.1 Global Injection Human Interleukin-2 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injection Human Interleukin-2 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injection Human Interleukin-2 Average Price by Manufacturers (2019-2024)
2.4 Global Injection Human Interleukin-2 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injection Human Interleukin-2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injection Human Interleukin-2, Product Type & Application
2.7 Injection Human Interleukin-2 Market Competitive Situation and Trends
2.7.1 Injection Human Interleukin-2 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injection Human Interleukin-2 Players Market Share by Revenue
2.7.3 Global Injection Human Interleukin-2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injection Human Interleukin-2 Retrospective Market Scenario by Region
3.1 Global Injection Human Interleukin-2 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injection Human Interleukin-2 Global Injection Human Interleukin-2 Sales by Region: 2019-2030
3.2.1 Global Injection Human Interleukin-2 Sales by Region: 2019-2024
3.2.2 Global Injection Human Interleukin-2 Sales by Region: 2025-2030
3.3 Global Injection Human Interleukin-2 Global Injection Human Interleukin-2 Revenue by Region: 2019-2030
3.3.1 Global Injection Human Interleukin-2 Revenue by Region: 2019-2024
3.3.2 Global Injection Human Interleukin-2 Revenue by Region: 2025-2030
3.4 North America Injection Human Interleukin-2 Market Facts & Figures by Country
3.4.1 North America Injection Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injection Human Interleukin-2 Sales by Country (2019-2030)
3.4.3 North America Injection Human Interleukin-2 Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injection Human Interleukin-2 Market Facts & Figures by Country
3.5.1 Europe Injection Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injection Human Interleukin-2 Sales by Country (2019-2030)
3.5.3 Europe Injection Human Interleukin-2 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection Human Interleukin-2 Market Facts & Figures by Country
3.6.1 Asia Pacific Injection Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injection Human Interleukin-2 Sales by Country (2019-2030)
3.6.3 Asia Pacific Injection Human Interleukin-2 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injection Human Interleukin-2 Market Facts & Figures by Country
3.7.1 Latin America Injection Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injection Human Interleukin-2 Sales by Country (2019-2030)
3.7.3 Latin America Injection Human Interleukin-2 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injection Human Interleukin-2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injection Human Interleukin-2 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injection Human Interleukin-2 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injection Human Interleukin-2 Sales by Type (2019-2030)
4.1.1 Global Injection Human Interleukin-2 Sales by Type (2019-2024)
4.1.2 Global Injection Human Interleukin-2 Sales by Type (2025-2030)
4.1.3 Global Injection Human Interleukin-2 Sales Market Share by Type (2019-2030)
4.2 Global Injection Human Interleukin-2 Revenue by Type (2019-2030)
4.2.1 Global Injection Human Interleukin-2 Revenue by Type (2019-2024)
4.2.2 Global Injection Human Interleukin-2 Revenue by Type (2025-2030)
4.2.3 Global Injection Human Interleukin-2 Revenue Market Share by Type (2019-2030)
4.3 Global Injection Human Interleukin-2 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injection Human Interleukin-2 Sales by Application (2019-2030)
5.1.1 Global Injection Human Interleukin-2 Sales by Application (2019-2024)
5.1.2 Global Injection Human Interleukin-2 Sales by Application (2025-2030)
5.1.3 Global Injection Human Interleukin-2 Sales Market Share by Application (2019-2030)
5.2 Global Injection Human Interleukin-2 Revenue by Application (2019-2030)
5.2.1 Global Injection Human Interleukin-2 Revenue by Application (2019-2024)
5.2.2 Global Injection Human Interleukin-2 Revenue by Application (2025-2030)
5.2.3 Global Injection Human Interleukin-2 Revenue Market Share by Application (2019-2030)
5.3 Global Injection Human Interleukin-2 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Clinigen
6.1.1 Clinigen Corporation Information
6.1.2 Clinigen Description and Business Overview
6.1.3 Clinigen Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Clinigen Injection Human Interleukin-2 Product Portfolio
6.1.5 Clinigen Recent Developments/Updates
6.2 3SBio
6.2.1 3SBio Corporation Information
6.2.2 3SBio Description and Business Overview
6.2.3 3SBio Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 3SBio Injection Human Interleukin-2 Product Portfolio
6.2.5 3SBio Recent Developments/Updates
6.3 Beijing Four Rings Biopharmaceutical
6.3.1 Beijing Four Rings Biopharmaceutical Corporation Information
6.3.2 Beijing Four Rings Biopharmaceutical Description and Business Overview
6.3.3 Beijing Four Rings Biopharmaceutical Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Beijing Four Rings Biopharmaceutical Injection Human Interleukin-2 Product Portfolio
6.3.5 Beijing Four Rings Biopharmaceutical Recent Developments/Updates
6.4 Jiangsu Kingsley Pharmaceutical
6.4.1 Jiangsu Kingsley Pharmaceutical Corporation Information
6.4.2 Jiangsu Kingsley Pharmaceutical Description and Business Overview
6.4.3 Jiangsu Kingsley Pharmaceutical Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Kingsley Pharmaceutical Injection Human Interleukin-2 Product Portfolio
6.4.5 Jiangsu Kingsley Pharmaceutical Recent Developments/Updates
6.5 Beijing Yuance Pharmaceutical
6.5.1 Beijing Yuance Pharmaceutical Corporation Information
6.5.2 Beijing Yuance Pharmaceutical Description and Business Overview
6.5.3 Beijing Yuance Pharmaceutical Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Beijing Yuance Pharmaceutical Injection Human Interleukin-2 Product Portfolio
6.5.5 Beijing Yuance Pharmaceutical Recent Developments/Updates
6.6 Beijing SL Pharm
6.6.1 Beijing SL Pharm Corporation Information
6.6.2 Beijing SL Pharm Description and Business Overview
6.6.3 Beijing SL Pharm Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Beijing SL Pharm Injection Human Interleukin-2 Product Portfolio
6.6.5 Beijing SL Pharm Recent Developments/Updates
6.7 Shanghai Huaxin Biotechnology
6.6.1 Shanghai Huaxin Biotechnology Corporation Information
6.6.2 Shanghai Huaxin Biotechnology Description and Business Overview
6.6.3 Shanghai Huaxin Biotechnology Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai Huaxin Biotechnology Injection Human Interleukin-2 Product Portfolio
6.7.5 Shanghai Huaxin Biotechnology Recent Developments/Updates
6.8 Changchun Institute Of Biological Products
6.8.1 Changchun Institute Of Biological Products Corporation Information
6.8.2 Changchun Institute Of Biological Products Description and Business Overview
6.8.3 Changchun Institute Of Biological Products Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Changchun Institute Of Biological Products Injection Human Interleukin-2 Product Portfolio
6.8.5 Changchun Institute Of Biological Products Recent Developments/Updates
6.9 Shandong Quangang Pharmaceutical
6.9.1 Shandong Quangang Pharmaceutical Corporation Information
6.9.2 Shandong Quangang Pharmaceutical Description and Business Overview
6.9.3 Shandong Quangang Pharmaceutical Injection Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shandong Quangang Pharmaceutical Injection Human Interleukin-2 Product Portfolio
6.9.5 Shandong Quangang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection Human Interleukin-2 Industry Chain Analysis
7.2 Injection Human Interleukin-2 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection Human Interleukin-2 Production Mode & Process
7.4 Injection Human Interleukin-2 Sales and Marketing
7.4.1 Injection Human Interleukin-2 Sales Channels
7.4.2 Injection Human Interleukin-2 Distributors
7.5 Injection Human Interleukin-2 Customers
8 Injection Human Interleukin-2 Market Dynamics
8.1 Injection Human Interleukin-2 Industry Trends
8.2 Injection Human Interleukin-2 Market Drivers
8.3 Injection Human Interleukin-2 Market Challenges
8.4 Injection Human Interleukin-2 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Injection Human Interleukin-2 Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Injection Human Interleukin-2 Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Injection Human Interleukin-2 Market Competitive Situation by Manufacturers in 2023
Table 4. Global Injection Human Interleukin-2 Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Injection Human Interleukin-2 Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Injection Human Interleukin-2 Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Injection Human Interleukin-2 Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Injection Human Interleukin-2 Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Injection Human Interleukin-2, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Injection Human Interleukin-2, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Injection Human Interleukin-2, Product Type & Application
Table 12. Global Key Manufacturers of Injection Human Interleukin-2, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injection Human Interleukin-2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Human Interleukin-2 as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injection Human Interleukin-2 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Injection Human Interleukin-2 Sales by Region (2019-2024) & (K Units)
Table 18. Global Injection Human Interleukin-2 Sales Market Share by Region (2019-2024)
Table 19. Global Injection Human Interleukin-2 Sales by Region (2025-2030) & (K Units)
Table 20. Global Injection Human Interleukin-2 Sales Market Share by Region (2025-2030)
Table 21. Global Injection Human Interleukin-2 Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Injection Human Interleukin-2 Revenue Market Share by Region (2019-2024)
Table 23. Global Injection Human Interleukin-2 Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Injection Human Interleukin-2 Revenue Market Share by Region (2025-2030)
Table 25. North America Injection Human Interleukin-2 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Injection Human Interleukin-2 Sales by Country (2019-2024) & (K Units)
Table 27. North America Injection Human Interleukin-2 Sales by Country (2025-2030) & (K Units)
Table 28. North America Injection Human Interleukin-2 Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Injection Human Interleukin-2 Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Injection Human Interleukin-2 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Injection Human Interleukin-2 Sales by Country (2019-2024) & (K Units)
Table 32. Europe Injection Human Interleukin-2 Sales by Country (2025-2030) & (K Units)
Table 33. Europe Injection Human Interleukin-2 Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Injection Human Interleukin-2 Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Injection Human Interleukin-2 Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Injection Human Interleukin-2 Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Injection Human Interleukin-2 Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Injection Human Interleukin-2 Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Injection Human Interleukin-2 Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Injection Human Interleukin-2 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Injection Human Interleukin-2 Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Injection Human Interleukin-2 Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Injection Human Interleukin-2 Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Injection Human Interleukin-2 Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Injection Human Interleukin-2 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Injection Human Interleukin-2 Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Injection Human Interleukin-2 Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Injection Human Interleukin-2 Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Injection Human Interleukin-2 Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Injection Human Interleukin-2 Sales (K Units) by Type (2019-2024)
Table 51. Global Injection Human Interleukin-2 Sales (K Units) by Type (2025-2030)
Table 52. Global Injection Human Interleukin-2 Sales Market Share by Type (2019-2024)
Table 53. Global Injection Human Interleukin-2 Sales Market Share by Type (2025-2030)
Table 54. Global Injection Human Interleukin-2 Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Injection Human Interleukin-2 Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Injection Human Interleukin-2 Revenue Market Share by Type (2019-2024)
Table 57. Global Injection Human Interleukin-2 Revenue Market Share by Type (2025-2030)
Table 58. Global Injection Human Interleukin-2 Price (US$/Unit) by Type (2019-2024)
Table 59. Global Injection Human Interleukin-2 Price (US$/Unit) by Type (2025-2030)
Table 60. Global Injection Human Interleukin-2 Sales (K Units) by Application (2019-2024)
Table 61. Global Injection Human Interleukin-2 Sales (K Units) by Application (2025-2030)
Table 62. Global Injection Human Interleukin-2 Sales Market Share by Application (2019-2024)
Table 63. Global Injection Human Interleukin-2 Sales Market Share by Application (2025-2030)
Table 64. Global Injection Human Interleukin-2 Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Injection Human Interleukin-2 Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Injection Human Interleukin-2 Revenue Market Share by Application (2019-2024)
Table 67. Global Injection Human Interleukin-2 Revenue Market Share by Application (2025-2030)
Table 68. Global Injection Human Interleukin-2 Price (US$/Unit) by Application (2019-2024)
Table 69. Global Injection Human Interleukin-2 Price (US$/Unit) by Application (2025-2030)
Table 70. Clinigen Corporation Information
Table 71. Clinigen Description and Business Overview
Table 72. Clinigen Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Clinigen Injection Human Interleukin-2 Product
Table 74. Clinigen Recent Developments/Updates
Table 75. 3SBio Corporation Information
Table 76. 3SBio Description and Business Overview
Table 77. 3SBio Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. 3SBio Injection Human Interleukin-2 Product
Table 79. 3SBio Recent Developments/Updates
Table 80. Beijing Four Rings Biopharmaceutical Corporation Information
Table 81. Beijing Four Rings Biopharmaceutical Description and Business Overview
Table 82. Beijing Four Rings Biopharmaceutical Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Beijing Four Rings Biopharmaceutical Injection Human Interleukin-2 Product
Table 84. Beijing Four Rings Biopharmaceutical Recent Developments/Updates
Table 85. Jiangsu Kingsley Pharmaceutical Corporation Information
Table 86. Jiangsu Kingsley Pharmaceutical Description and Business Overview
Table 87. Jiangsu Kingsley Pharmaceutical Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Jiangsu Kingsley Pharmaceutical Injection Human Interleukin-2 Product
Table 89. Jiangsu Kingsley Pharmaceutical Recent Developments/Updates
Table 90. Beijing Yuance Pharmaceutical Corporation Information
Table 91. Beijing Yuance Pharmaceutical Description and Business Overview
Table 92. Beijing Yuance Pharmaceutical Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Beijing Yuance Pharmaceutical Injection Human Interleukin-2 Product
Table 94. Beijing Yuance Pharmaceutical Recent Developments/Updates
Table 95. Beijing SL Pharm Corporation Information
Table 96. Beijing SL Pharm Description and Business Overview
Table 97. Beijing SL Pharm Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Beijing SL Pharm Injection Human Interleukin-2 Product
Table 99. Beijing SL Pharm Recent Developments/Updates
Table 100. Shanghai Huaxin Biotechnology Corporation Information
Table 101. Shanghai Huaxin Biotechnology Description and Business Overview
Table 102. Shanghai Huaxin Biotechnology Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Shanghai Huaxin Biotechnology Injection Human Interleukin-2 Product
Table 104. Shanghai Huaxin Biotechnology Recent Developments/Updates
Table 105. Changchun Institute Of Biological Products Corporation Information
Table 106. Changchun Institute Of Biological Products Description and Business Overview
Table 107. Changchun Institute Of Biological Products Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Changchun Institute Of Biological Products Injection Human Interleukin-2 Product
Table 109. Changchun Institute Of Biological Products Recent Developments/Updates
Table 110. Shandong Quangang Pharmaceutical Corporation Information
Table 111. Shandong Quangang Pharmaceutical Description and Business Overview
Table 112. Shandong Quangang Pharmaceutical Injection Human Interleukin-2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shandong Quangang Pharmaceutical Injection Human Interleukin-2 Product
Table 114. Shandong Quangang Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Injection Human Interleukin-2 Distributors List
Table 118. Injection Human Interleukin-2 Customers List
Table 119. Injection Human Interleukin-2 Market Trends
Table 120. Injection Human Interleukin-2 Market Drivers
Table 121. Injection Human Interleukin-2 Market Challenges
Table 122. Injection Human Interleukin-2 Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injection Human Interleukin-2
Figure 2. Global Injection Human Interleukin-2 Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Injection Human Interleukin-2 Market Share by Type in 2023 & 2030
Figure 4. 50000 IU Product Picture
Figure 5. 100000 IU Product Picture
Figure 6. 200000 IU Product Picture
Figure 7. 500000 IU Product Picture
Figure 8. 1 Million IU Product Picture
Figure 9. Other Product Picture
Figure 10. Global Injection Human Interleukin-2 Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Injection Human Interleukin-2 Market Share by Application in 2023 & 2030
Figure 12. Hospital
Figure 13. Pharmacy
Figure 14. Global Injection Human Interleukin-2 Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Injection Human Interleukin-2 Market Size (2019-2030) & (US$ Million)
Figure 16. Global Injection Human Interleukin-2 Sales (2019-2030) & (K Units)
Figure 17. Global Injection Human Interleukin-2 Average Price (US$/Unit) & (2019-2030)
Figure 18. Injection Human Interleukin-2 Report Years Considered
Figure 19. Injection Human Interleukin-2 Sales Share by Manufacturers in 2023
Figure 20. Global Injection Human Interleukin-2 Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Injection Human Interleukin-2 Players: Market Share by Revenue in 2023
Figure 22. Injection Human Interleukin-2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Injection Human Interleukin-2 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Injection Human Interleukin-2 Sales Market Share by Country (2019-2030)
Figure 25. North America Injection Human Interleukin-2 Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Injection Human Interleukin-2 Sales Market Share by Country (2019-2030)
Figure 29. Europe Injection Human Interleukin-2 Revenue Market Share by Country (2019-2030)
Figure 30. Germany Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Injection Human Interleukin-2 Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Injection Human Interleukin-2 Revenue Market Share by Region (2019-2030)
Figure 37. China Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Injection Human Interleukin-2 Sales Market Share by Country (2019-2030)
Figure 48. Latin America Injection Human Interleukin-2 Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Injection Human Interleukin-2 Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Injection Human Interleukin-2 Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Injection Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Injection Human Interleukin-2 by Type (2019-2030)
Figure 58. Global Revenue Market Share of Injection Human Interleukin-2 by Type (2019-2030)
Figure 59. Global Injection Human Interleukin-2 Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Injection Human Interleukin-2 by Application (2019-2030)
Figure 61. Global Revenue Market Share of Injection Human Interleukin-2 by Application (2019-2030)
Figure 62. Global Injection Human Interleukin-2 Price (US$/Unit) by Application (2019-2030)
Figure 63. Injection Human Interleukin-2 Value Chain
Figure 64. Injection Human Interleukin-2 Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
